TIZONA THERAPEUTICS Trademark

Trademark Overview

On Wednesday, June 10, 2015, a trademark application was filed for TIZONA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the TIZONA THERAPEUTICS trademark a serial number of 86984567. The federal status of this trademark filing is REGISTERED as of Tuesday, October 27, 2020. This trademark is owned by Vesuvius Pharmaceuticals, Inc.. The TIZONA THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of pharmaceuticals and compounds for the treatment of cancer and autoimmune diseases; research and development of pharmaceuticals and compounds for modulation of the immune system and the tumor microenvironment
tizona therapeutics

General Information

Serial Number86984567
Word MarkTIZONA THERAPEUTICS
Filing DateWednesday, June 10, 2015
Status700 - REGISTERED
Status DateTuesday, October 27, 2020
Registration Number6185401
Registration DateTuesday, October 27, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 8, 2015

Trademark Statements

NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesResearch and development of pharmaceuticals and compounds for the treatment of cancer and autoimmune diseases; research and development of pharmaceuticals and compounds for modulation of the immune system and the tumor microenvironment

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, June 15, 2015
Primary Code042
First Use Anywhere DateMonday, May 16, 2016
First Use In Commerce DateMonday, May 16, 2016

Trademark Owner History

Party NameTIZONA THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameTIZONA THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameVesuvius Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138
Party NameVesuvius Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138

Trademark Events

Event DateEvent Description
Saturday, June 13, 2015NEW APPLICATION ENTERED
Monday, June 15, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 19, 2015ASSIGNED TO EXAMINER
Saturday, September 26, 2015EXAMINERS AMENDMENT -WRITTEN
Saturday, September 26, 2015EXAMINERS AMENDMENT E-MAILED
Saturday, September 26, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, September 26, 2015EXAMINER'S AMENDMENT ENTERED
Saturday, September 26, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 4, 2015ASSIGNED TO LIE
Wednesday, November 4, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 18, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 8, 2015PUBLISHED FOR OPPOSITION
Tuesday, December 8, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, January 13, 2016AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, February 2, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, June 29, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 29, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, June 29, 2016SOU EXTENSION 1 FILED
Wednesday, June 29, 2016SOU EXTENSION 1 GRANTED
Friday, July 1, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 15, 2016SOU TEAS EXTENSION RECEIVED
Thursday, December 15, 2016SOU EXTENSION 2 FILED
Thursday, December 15, 2016SOU EXTENSION 2 GRANTED
Saturday, December 17, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 17, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 17, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 16, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 16, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 2, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, August 2, 2017SOU EXTENSION 3 FILED
Wednesday, August 2, 2017SOU EXTENSION 3 GRANTED
Friday, August 4, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 31, 2018SOU TEAS EXTENSION RECEIVED
Wednesday, January 31, 2018SOU EXTENSION 4 FILED
Wednesday, January 31, 2018SOU EXTENSION 4 GRANTED
Friday, February 2, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 1, 2018SOU TEAS EXTENSION RECEIVED
Wednesday, August 8, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 1, 2018SOU EXTENSION 5 FILED
Wednesday, August 8, 2018SOU EXTENSION 5 GRANTED
Thursday, August 9, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 31, 2019TEAS STATEMENT OF USE RECEIVED
Thursday, January 31, 2019TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, February 5, 2019ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Monday, February 11, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 31, 2020DIVISIONAL REQUEST RECEIVED
Wednesday, June 24, 2020DIVISIONAL PROCESSING COMPLETE
Thursday, January 31, 2019USE AMENDMENT FILED
Wednesday, June 24, 2020STATEMENT OF USE PROCESSING COMPLETE
Monday, July 27, 2020SU - NON-FINAL ACTION - WRITTEN
Monday, July 27, 2020NON-FINAL ACTION E-MAILED
Monday, July 27, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 9, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 9, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 9, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 24, 2020SU-EXAMINER'S AMENDMENT WRITTEN
Thursday, September 24, 2020EXAMINERS AMENDMENT E-MAILED
Thursday, September 24, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, September 24, 2020EXAMINER'S AMENDMENT ENTERED
Thursday, September 24, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, September 25, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 27, 2020REGISTERED-PRINCIPAL REGISTER
Monday, October 27, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

therapeutics tizona research pharmaceuticals compounds development system tumor microenvironment immune autoimmune treatment